TRIO CTO (Taiwan Research Initiative on Coronary Total Occlusion)
ConditionChronic Total Occlusion (CTO)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age20-120
SponsorNational Taiwan University Hospital
About this trial
Coronary chronic total occlusions (CTO) present a significant challenge in the field of interventional cardiology. These complex lesions, characterized by complete blockage of a coronary artery for a prolonged duration, often require specialized techniques and strategies to achieve successful revascularization.
Eligibility criteria
Qualifiers
Over 20 years old
Chronic total occlusion confirmed by coronary angiography, and noted for more than 3 months
Disqualifiers
None
Trial design
Treatments tested in this trial
- Percutaneous coronary intervention of coronary chronic total occlusion
Treatment groups
5,000 Participants
are divided into 3 treatment groupsSponsors and collaborators
National Taiwan University Hospital
Lead sponsor
Chang Gung Memorial Hospital
Collaborator
Taipei Veterans General Hospital, Taiwan
Collaborator
Source ClinicalTrials.gov